Chemokine ‑ and chemokine receptor-based subtypes predict prognosis, immunotherapy and chemotherapy response in colorectal cancer patients

CONCLUSION: We first established robust prognostic subtypes based on chemokines and chemokine receptors, which could potentially serve as a novel biomarker for guiding individualized treatment in patients with CRC undergoing immunotherapy and chemotherapy.PMID:38703566 | DOI:10.1016/j.intimp.2024.112172

Source: International Immunopharmacology - May 4, 2024 Category: Allergy & Immunology Authors: Wenjie Zhu Shimin Zhao Xiufeng Cheng Changlei Wu Zitao Liu Jun Huang Source Type: research